HOOKIPA files Section 205 petition to validate 2022/2023 stockholder actions due to record date errors; hearing Feb 14

HOOKIPA Pharma Inc.

Record date for 2022 annual meeting was 78 days before the meeting (April 13 vs. June 30, 2022), violating DGCL 60-day limit.
Record date for 2023 annual meeting was 66 days before the meeting (April 4 vs. June 9, 2023), also noncompliant.
Petition seeks validation of 2022 share increase (100M to 200M shares), plan amendment, and director elections from both meetings.
As of April 2024, over 36.6M shares may be invalid if 2022 amendment is not validated, affecting subsequent corporate actions.
Delaware Chancery Court will hold final hearing on Feb 14, 2025; stockholders may appear or submit written positions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.